Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00615771 · ClinicalTrials.gov registry record · NA
Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT00615771: Completed NA study, sponsored by Stanford University.
NCT00615771 is a NA study that has completed, run by Stanford University. The registered enrollment target is 242 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00615771, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
We are examining whether pregnancy rates differ based on day of embryo transfer in patients who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must be undergoing IVF treatment at Stanford University and patients will not receive compensation for their participation (no medical costs covered or patient payment for participation).
Interventions
- PROCEDURE Day 3 embryo transfer
- PROCEDURE Day 2 embryo transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-03 |
| Phase | NA |
What the finished NCT00615771 record still lists
NCT00615771 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Day 3 embryo transfer is the first listed.
NCT00615771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00615771 about?
NCT00615771 is a clinical study titled "Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization". We are examining whether pregnancy rates differ based on day of embryo transfer in patients who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must be undergoing IVF treatment at Stanford University and patients will not receive compensation for their participati...
What is the current status of trial NCT00615771?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2007-01. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00615771?
The interventions under investigation include: Day 3 embryo transfer (PROCEDURE), Day 2 embryo transfer (PROCEDURE).
Who is sponsoring clinical trial NCT00615771?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00615771's enrollment target sits among peer trials
242 439th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia